Surgery Partners Stock Forecast for 2023 - 2025 - 2030
Updated on 04/19/2024
Surgery Partners Stock Forecast and Price Target
According to esteemed experts, the average price target for Surgery Partners to reach this year is $43.00, with a potential upside of approximately 83.6%. This prediction is based on a high estimate of $50.00 and a low estimate of $35.00. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?
83.60% Upside
Surgery Partners Fair Value Forecast for 2023 - 2025 - 2030
Surgery Partners's Price has grown In the last four years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $25.25 – an increase of 100.00%. For the next seven years, experts predict that Surgery Partners's Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HCA Stock Forecast | HCA Healthcare | Outperform |
18
|
$297.00 | Buy/Sell | $319.61 | 15.72% |
| UHS Stock Forecast | Universal Health Services | Outperform |
6
|
$153.65 | Buy/Sell | $162.38 | 21.71% |
| THC Stock Forecast | Tenet Healthcare | Outperform |
15
|
$91.08 | Buy/Sell | $86.63 | 24.07% |
| CHE Stock Forecast | Chemed Corp | Outperform |
18
|
$597.42 | Buy/Sell | $611.33 | 16.58% |
| ACHC Stock Forecast | Acadia Healthcare Company | Outperform |
15
|
$70.28 | Buy/Sell | $89.55 | 42.29% |
Surgery Partners Revenue Forecast for 2023 - 2025 - 2030
Surgery Partners's Revenue has grown In the last three years, rising from $1.86B to $2.74B – a growth of 47.48%. In the next year, analysts believe that Revenue will reach $3.00B – an increase of 9.21%. For the next seven years, experts predict that Surgery Partners's Revenue will grow at a rate of 29.10%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| EHC Stock Forecast | Encompass Health | Buy |
18
|
$78.62 | Buy/Sell | $84.00 | 14.47% |
| ENSG Stock Forecast | The Ensign Group | Outperform |
18
|
$116.48 | Buy/Sell | $119.25 | 14.18% |
| OPCH Stock Forecast | Option Care Health | Buy |
14
|
$30.90 | Buy/Sell | $0.00 | 25.57% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LHCG Stock Forecast | LHC Group | - |
14
|
$169.81 | Buy/Sell | $170.00 | -100.00% |
| SEM Stock Forecast | Select Medical Holdings | Outperform |
16
|
$26.43 | Buy/Sell | $32.80 | 36.21% |
| AMED Stock Forecast | Amedisys | Hold |
16
|
$90.78 | Buy/Sell | $97.00 | 11.26% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AMN Stock Forecast | AMN Healthcare Services | Outperform |
16
|
$56.30 | Buy/Sell | $86.13 | 34.10% |
| USPH Stock Forecast | U.S. Physical Therapy | Outperform |
18
|
$97.49 | Buy/Sell | $108.40 | 23.09% |
| NHC Stock Forecast | National HealthCare | - |
18
|
$87.95 | Buy/Sell | $47.00 | -100.00% |
Surgery Partners EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Surgery Partners's EBITDA has grown, moving from $284.40M to $533.00M – an increase of 87.41%. In the following year, 9 experts forecast Surgery Partners's EBITDA will decrease by 8.13%, to $489.65M. Looking ahead to seven years, experts forecast that EBITDA will grow by 7.95%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BKD Stock Forecast | Brookdale Senior Living | Outperform |
10
|
$6.52 | Buy/Sell | $6.48 | 18.87% |
| MD Stock Forecast | Pediatrix Medical Group | Hold |
12
|
$8.81 | Buy/Sell | $9.86 | 2.16% |
| CYH Stock Forecast | Community Health Systems | Outperform |
11
|
$2.78 | Buy/Sell | $4.98 | 52.88% |
Surgery Partners EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Surgery Partners's EBIT has seen an increase, rising from $189.60M to $414.90M. This represents a growth of 118.83%. Analysts predict that Surgery Partners's EBIT will increase in the upcoming year, reaching $469.77M. This would represent an increase of 13.22%. Over the next seven years, experts predict that Surgery Partners's EBIT will grow at a rate of 10.66%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AKUM.Q Stock Forecast | Akumin | - |
11
|
$0.38 | Buy/Sell | $0.55 | -100.00% |
| SSY Stock Forecast | SunLink Health Systems | - |
0
|
$0.90 | Buy/Sell | $0.00 | -100.00% |
| GENN Stock Forecast | Genesis Healthcare | - |
4
|
$0.00 | Buy/Sell | $0.01 | 0.00% |
Surgery Partners EPS Price Prediction Forecast for 2023 - 2025 - 2030
Surgery Partners's EPS has grown In the last four years, rising from $-1.22 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $0.96 – an increase of 100.00%. For the next seven years, experts predict that Surgery Partners's EPS will grow at a rate of 100.00%.
.jpg)